Clearmind Medicine (NASDAQ:CMND – Get Free Report) issued its earnings results on Thursday. The company reported ($0.24) earnings per share for the quarter, Zacks reports.
Clearmind Medicine Trading Up 0.9 %
Shares of CMND stock opened at $1.14 on Friday. The stock has a market capitalization of $4.86 million, a PE ratio of -0.61 and a beta of 1.02. Clearmind Medicine has a 1-year low of $0.95 and a 1-year high of $2.30. The business has a 50-day moving average of $1.35 and a 200 day moving average of $1.36. The company has a debt-to-equity ratio of 0.01, a current ratio of 1.72 and a quick ratio of 1.72.
Clearmind Medicine Company Profile
Featured Stories
- Five stocks we like better than Clearmind Medicine
- What is the Euro STOXX 50 Index?
- Casey’s Uptrend Remains Strong—New Highs on the Horizon
- High Flyers: 3 Natural Gas Stocks for March 2022
- Taiwan Semiconductor’s Huge U.S. Move—Stock Impact Ahead
- Most active stocks: Dollar volume vs share volume
- Why Costco Stock Is Poised to Hit $1,000 Again Soon
Receive News & Ratings for Clearmind Medicine Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clearmind Medicine and related companies with MarketBeat.com's FREE daily email newsletter.